Literature DB >> 11196108

Trifunctional protein deficiency: three families with significant maternal hepatic dysfunction in pregnancy not associated with E474Q mutation.

A Chakrapani1, S Olpin, M Cleary, J H Walter, J E Wraith, G T Besley.   

Abstract

We report five families with trifunctional protein deficiency in which, during pregnancy, three mothers experienced significant hepatic disease when carrying an affected fetus. Diagnoses were based on increased levels of long-chain hydroxyacylcarnitines and deficiencies of 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and 3-ketoacyl-CoA thiolase activity in fibroblasts. All affected infants lacked the common E474Q mutation associated with isolated LCHAD deficiency. This mutation is thought to be a predisposing factor for maternal hepatic disease in pregnancy. Our findings suggest that other defects in this enzyme complex might be responsible for maternal hepatic complications in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196108     DOI: 10.1023/a:1026712719416

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation.

Authors:  R J Wanders; L IJlst; A H van Gennip; C Jakobs; J P de Jager; L Dorland; F J van Sprang; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.

Authors:  N J Manning; S E Olpin; R J Pollitt; J Webley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy.

Authors:  A Mansouri; B Fromenty; F Durand; C Degott; J Bernuau; D Pessayre
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

4.  Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.

Authors:  L IJlst; J P Ruiter; J M Hoovers; M E Jakobs; R J Wanders
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.

Authors:  J A Ibdah; M J Bennett; P Rinaldo; Y Zhao; B Gibson; H F Sims; A W Strauss
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

Review 6.  Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications.

Authors:  A W Strauss; M J Bennett; P Rinaldo; H F Sims; L K O'Brien; Y Zhao; B Gibson; J Ibdah
Journal:  Semin Perinatol       Date:  1999-04       Impact factor: 3.300

7.  Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.

Authors:  W R Treem; P Rinaldo; D E Hale; C A Stanley; D S Millington; J S Hyams; S Jackson; D M Turnbull
Journal:  Hepatology       Date:  1994-02       Impact factor: 17.425

8.  Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients.

Authors:  H Reyes; L Sandoval; A Wainstein; J Ribalta; S Donoso; G Smok; H Rosenberg; M Meneses
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

Authors:  B M Sibai; M K Ramadan; I Usta; M Salama; B M Mercer; S A Friedman
Journal:  Am J Obstet Gynecol       Date:  1993-10       Impact factor: 8.661

10.  Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring.

Authors:  M N Schoeman; R G Batey; B Wilcken
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

View more
  4 in total

1.  Fatty acid oxidation in the human fetus: implications for fetal and adult disease.

Authors:  Nadia A Oey; Jos P N Ruiter; Tania Attié-Bitach; Lodewijk Ijlst; Ronald J A Wanders; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

2.  Acute fatty liver of pregnancy and neonatal long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency.

Authors:  Carolina Gutiérrez Junquera; Elena Balmaseda; Esther Gil; Andrés Martínez; Moisés Sorli; Isabel Cuartero; Begoña Merinero; Magdalena Ugarte
Journal:  Eur J Pediatr       Date:  2008-04-12       Impact factor: 3.183

3.  High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease.

Authors:  N A Oey; M E J den Boer; J P N Ruiter; R J A Wanders; M Duran; H R Waterham; K Boer; J A M van der Post; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

Review 4.  Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.

Authors:  Simon E Olpin
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.